|
|
.
See Category: Diseases of the genitourinary system
ICD-10 (CM) Code and Descriptor
|
N83.8 |
Other noninflammatory disorders of ovary, fallopian tube and broad ligament
Diagnosis Valid for Female Patient Only
|
N838 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 27.70%
|
21.79%
|
16.66%
|
11.88%
|
7.82%
|
4.98%
|
3.12%
|
1.99%
|
1.14%
|
0.89%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for N83.8*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
76830
|
TRANSVAGINAL US NON-OB |
2,037
|
2,037
|
|
76856
|
US EXAM PELVIC COMPLETE |
1,973
|
1,973
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
1,890
|
1,903
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,518
|
1,520
|
|
86304
|
IMMUNOASSAY TUMOR CA 125 |
1,343
|
1,343
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
1,035
|
1,035
|
|
80053
|
COMPREHEN METABOLIC PANEL |
890
|
890
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
754
|
70,706
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
719
|
719
|
|
J2405
|
ONDANSETRON HCL INJECTION |
680
|
3,118
|
|
J3010
|
FENTANYL CITRATE INJECTION |
581
|
1,103
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
571
|
2,300
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
523
|
747
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
498
|
14,014
|
|
72197
|
MRI PELVIS W/O & W/DYE |
488
|
488
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
439
|
2,656
|
|
82378
|
CARCINOEMBRYONIC ANTIGEN |
437
|
437
|
|
86900
|
BLOOD TYPING SEROLOGIC ABO |
436
|
444
|
|
86901
|
BLOOD TYPING SEROLOGIC RH(D) |
434
|
442
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
423
|
3,299
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
N83.8 related to the following DRG Codes:
742-743
760-761
|
